Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing
NCT ID: NCT07141394
Last Updated: 2025-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
7908 participants
INTERVENTIONAL
2026-10-01
2030-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LINK: Aftercare Monitoring Project
NCT00265512
Improving Linkage to Health and Other Services for Veterans Leaving Incarceration
NCT02964897
TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification
NCT02269787
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
NCT02382042
Impact of Work Activity on SUD Outcomes
NCT04969081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Replicating Effective Programs (REP)
A stakeholder-informed training and technical assistance implementation strategy
Medication for Addiction Treatment (MAT)
MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.
Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)
An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.
REP + Consumer Engagement (CE)
REP plus CE package (educational materials, peer coaching, toolkit) to support MAT and CBT-SUD implementation.
Medication for Addiction Treatment (MAT)
MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.
Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)
An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.
Control Group
No MAT or CBT-SUD implementation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication for Addiction Treatment (MAT)
MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.
Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)
An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sonya Emi Gabrielian, MD MPH
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Evelyn T Chang, MD MSHS
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System, Sepulveda, CA
Erin P Finley, PhD MPH
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Emily Treichler, PhD
Role: PRINCIPAL_INVESTIGATOR
VA San Diego Healthcare System, San Diego, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QUE 25-013
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
QUX 25-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.